Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Stereotaxis, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of STXS: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders97193−3
Shares42.5M375.0K40.2M−1.90M (−4.5%)
Value$263.4M$2.33M$150.1M−$111.0M (−42.5%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Stereotaxis, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to STXS in Q1 2022
InstitutionSharesValue% of portfolio
GMT Capital Corp126,581$472.0K0.03%
Renaissance Technologies LLC72,100$269.0K0.00%
Walleye Capital LLC21,777$81.0K0.00%
Atom Investors LP20,549$77.0K0.04%
Wellington Shields & Co., LLC15,500$58.0K0.02%
Cubist Systematic Strategies, LLC11,290$42.0K0.00%
Amalgamated Bank8,107$30.0K0.00%
Amalgamated Financial Corp.8,107$30.0K0.00%
Money Concepts Capital Corp3,000$11.0K0.00%
FMR LLC234$1.00K0.00%
Aspire Private Capital, LLC200$1.00K0.00%
Simplex Trading, LLC142$00.00%
Capital Advisory Group Advisory Services, LLC15$00.00%

Sold out (16)

Institutions that held Stereotaxis, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Not filed for Q1 2022 yet (1)

Institutions that held Stereotaxis, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STXS in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
AlphaCentric Advisors LLC375,000$2.33M